Chen M L, Boltz M, Christakos S, Armbrecht H J
Geriatric Research, Education, and Clinical Center, Veterans Affairs Medical Center, St. Louis, Missouri 63125.
Endocrinology. 1992 Jun;130(6):3295-300. doi: 10.1210/endo.130.6.1597142.
In vivo studies have indicated that renal calbindin-D28K protein and mRNA levels decrease in adult and old rats, and this decrease parallels the age-associated decline in serum 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] levels. However, diminished renal responsiveness to 1,25-(OH)2D3 with advancing age could also contribute to decreased calbindin-D28K expression. To study renal responsiveness with age, primary cell cultures were established from the kidney cortices of young (1 month old), adult (10-12 months old), and old (20-24 months old) rats. Cells were incubated in medium K-1 containing 2% fetal calf serum. Calbindin-D28K protein levels were determined by Western blot and enzyme-linked immunosorbent assay. In young animals, the levels of calbindin-D28K declined from 12.1 +/- 1.3 micrograms/mg protein in the intact kidney to 1.6 +/- 0.07 micrograms/mg protein in cells that had been cultured for 3 days in the absence of 1,25-(OH)2D3. This sharp decline in calbindin-D28K protein concentration moderated by days 6-8. The continuous presence of 10(-7) M 1,25-(OH)2D3 in the medium did not abolish the decline. The low levels of calbindin-D28K in the cells cultured in the absence of 1,25-(OH)2D3 provided an excellent experimental system in which to compare the response of the cells to 1,25-(OH)2D3 between age groups. In cultured cells treated with 1,25-(OH)2D3 for 72 h, calbindin-D28K induction was greater in cells from adult and old animals compared to cells from young animals. The ratios of calbindin-D28K content (with vitamin D/without vitamin D) were 2.2 +/- 0.2, 4.7 +/- 0.5, and 7.1 +/- 1.5 for young, adult, and old cells, respectively. These studies suggested that the observed in vivo decrease in renal calbindin-D28K with age is primarily due to the lowered circulating 1,25-(OH)2D3.
体内研究表明,成年和老年大鼠肾脏钙结合蛋白-D28K的蛋白质和mRNA水平降低,且这种降低与血清1,25-二羟维生素D3[1,25-(OH)2D3]水平随年龄增长而下降的情况平行。然而,随着年龄增长肾脏对1,25-(OH)2D3的反应性降低也可能导致钙结合蛋白-D28K表达减少。为了研究肾脏反应性随年龄的变化,从幼年(1月龄)、成年(10-12月龄)和老年(20-24月龄)大鼠的肾皮质建立原代细胞培养物。细胞在含有2%胎牛血清的K-1培养基中孵育。通过蛋白质印迹法和酶联免疫吸附测定法测定钙结合蛋白-D28K的蛋白质水平。在幼年动物中,完整肾脏中钙结合蛋白-D28K的水平从12.1±1.3微克/毫克蛋白质下降到在无1,25-(OH)2D3的情况下培养3天的细胞中的1.6±0.07微克/毫克蛋白质。钙结合蛋白-D28K蛋白质浓度的这种急剧下降在第6-8天有所缓和。培养基中持续存在10-7M的1,25-(OH)2D3并没有消除这种下降。在无1,25-(OH)2D3的情况下培养的细胞中钙结合蛋白-D28K的低水平提供了一个极好的实验系统,用于比较不同年龄组细胞对1,25-(OH)2D3的反应。在用1,25-(OH)2D3处理72小时的培养细胞中,成年和老年动物来源的细胞中钙结合蛋白-D28K的诱导作用比幼年动物来源的细胞更大。幼年、成年和老年细胞的钙结合蛋白-D28K含量(有维生素D/无维生素D)之比分别为2.2±0.2、4.7±0.5和7.1±1.5。这些研究表明,观察到的肾脏钙结合蛋白-D28K随年龄增长在体内的减少主要是由于循环中1,25-(OH)2D3水平降低。